[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BG101983A - Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване - Google Patents

Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване

Info

Publication number
BG101983A
BG101983A BG101983A BG10198397A BG101983A BG 101983 A BG101983 A BG 101983A BG 101983 A BG101983 A BG 101983A BG 10198397 A BG10198397 A BG 10198397A BG 101983 A BG101983 A BG 101983A
Authority
BG
Bulgaria
Prior art keywords
preparation
mehtod
forms containing
phenylamidines
substituted phenylamidines
Prior art date
Application number
BG101983A
Other languages
English (en)
Other versions
BG63385B1 (bg
Inventor
Frank Himmelsbach
Volkhard Austel
Guenter Linz
Helmut Pieper
Brian Guth
Johannes Weisenberger
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of BG101983A publication Critical patent/BG101983A/bg
Publication of BG63385B1 publication Critical patent/BG63385B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретението се отнася до фениламидини с обща формула, в която радикалите имат значенията, посочени в описанието, до тавтомери, стереоизомери, включително смеси от тях и техните соли, по-специално до техните физиологични поносими соли с неорганичниили органични киселини или бази. Те имат ценни фармакологични свойства, по-специално задържаща съсирването активност. Изобретениетосе отнася също до лекарствени средства, които съдържат посочените съединения, до приложението им и до метод за получаването им.
BG101983A 1995-04-27 1997-10-20 Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване BG63385B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19515500A DE19515500A1 (de) 1995-04-27 1995-04-27 Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
PCT/EP1996/001615 WO1996033970A1 (de) 1995-04-27 1996-04-18 Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
BG101983A true BG101983A (bg) 1998-04-30
BG63385B1 BG63385B1 (bg) 2001-12-29

Family

ID=7760507

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101983A BG63385B1 (bg) 1995-04-27 1997-10-20 Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване

Country Status (24)

Country Link
US (1) US5958952A (bg)
EP (1) EP0824515B1 (bg)
JP (1) JPH11504630A (bg)
KR (1) KR19990008011A (bg)
AT (1) ATE200277T1 (bg)
AU (1) AU703946B2 (bg)
BG (1) BG63385B1 (bg)
BR (1) BR9608038A (bg)
CA (1) CA2219337A1 (bg)
CZ (1) CZ288764B6 (bg)
DE (2) DE19515500A1 (bg)
DK (1) DK0824515T3 (bg)
EE (1) EE03919B1 (bg)
ES (1) ES2158309T3 (bg)
GR (1) GR3036023T3 (bg)
HU (1) HU222050B1 (bg)
NO (1) NO309422B1 (bg)
NZ (1) NZ306451A (bg)
PL (1) PL184276B1 (bg)
PT (1) PT824515E (bg)
RU (1) RU2167857C2 (bg)
SK (1) SK282232B6 (bg)
TR (1) TR199701258T1 (bg)
WO (1) WO1996033970A1 (bg)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877174A (en) * 1994-12-01 1999-03-02 Toyama Chemical Co., Ltd. 2,3-diketopiperazine derivatives or their salts
US5942544A (en) * 1996-02-22 1999-08-24 Dupont Pharmaceuticals Company α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
DE19833105A1 (de) * 1998-07-23 2000-01-27 Boehringer Ingelheim Pharma Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US6242466B1 (en) 1998-07-23 2001-06-05 Boehringer Ingelheim Pharma Kg Substituted phenylamidines
DE10002510A1 (de) * 2000-01-21 2001-07-26 Boehringer Ingelheim Pharma Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
US5256812A (en) * 1989-01-31 1993-10-26 Hoffmann-La Roche Inc. Carboxamides and sulfonamides
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5254573A (en) * 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
JPH07500335A (ja) * 1991-10-15 1995-01-12 モンサント　カンパニー 血小板凝集抑制剤として有用な置換複素環誘導体

Also Published As

Publication number Publication date
EP0824515A1 (de) 1998-02-25
JPH11504630A (ja) 1999-04-27
DK0824515T3 (da) 2001-07-09
CZ340697A3 (cs) 1998-04-15
SK282232B6 (sk) 2001-12-03
NO974945L (no) 1997-10-24
AU5500896A (en) 1996-11-18
ES2158309T3 (es) 2001-09-01
TR199701258T1 (xx) 1998-03-21
CZ288764B6 (cs) 2001-08-15
HUP9801228A3 (en) 1998-09-28
US5958952A (en) 1999-09-28
PL322969A1 (en) 1998-03-02
DE59606725D1 (de) 2001-05-10
NO974945D0 (no) 1997-10-24
CA2219337A1 (en) 1996-10-31
KR19990008011A (ko) 1999-01-25
PL184276B1 (pl) 2002-09-30
EP0824515B1 (de) 2001-04-04
EE9700292A (et) 1998-06-15
NZ306451A (en) 1999-05-28
SK144397A3 (en) 1998-05-06
RU2167857C2 (ru) 2001-05-27
HUP9801228A2 (hu) 1998-08-28
GR3036023T3 (en) 2001-09-28
NO309422B1 (no) 2001-01-29
HU222050B1 (hu) 2003-04-28
BR9608038A (pt) 1999-01-12
WO1996033970A1 (de) 1996-10-31
EE03919B1 (et) 2002-12-16
AU703946B2 (en) 1999-04-01
DE19515500A1 (de) 1996-10-31
PT824515E (pt) 2001-09-28
MX9708021A (es) 1998-03-31
ATE200277T1 (de) 2001-04-15
BG63385B1 (bg) 2001-12-29

Similar Documents

Publication Publication Date Title
BG101339A (bg) 2-арилзаместени пиридини
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
AU7194094A (en) Fabric scenting method
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
BG101139A (bg) Съдържащи хетероатоми циклопентанопиридилоксазолидинони
AU6045794A (en) PF1022 derivative cyclic depsipeptide
AU6972591A (en) Improved iontophoretic delivery method
MY128335A (en) Glycopeptide antibiotic derivatives
EP0817797A4 (en) DERIVATIVES OF GLYCOPEPTIDANTIBIOTICS
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
IL98699A0 (en) Sterilant mixture and sterilization method
DE69433793D1 (de) Phosphorderivate zur behandlung von aids
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
IT1234817B (it) Tappeto per idromassaggi.
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
BG101983A (bg) Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване
AU2572588A (en) Method for preparing textile treatment compositions
DE68919166D1 (de) Hochorientierter Dauermagnet und Verfahren zu seiner Herstellung.
AU2334495A (en) Pyrrolidine stereoisomers
DE69205601D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethylcyclohexanon.
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
LTIP620A (en) Novel phospholipide derivatives
AU4545189A (en) Lipid emulsion for treating aids